Verrica Pharmaceuticals Inc (VRCA)
9.21
+0.06
(+0.66%)
USD |
NASDAQ |
May 17, 11:18
Verrica Pharmaceuticals Gross Profit Margin (Quarterly): 70.26% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 70.26% |
December 31, 2023 | 86.32% |
September 30, 2023 | 90.74% |
June 30, 2023 | 25.27% |
March 31, 2023 | -83.78% |
Date | Value |
---|---|
December 31, 2022 | 8.82% |
September 30, 2022 | 98.00% |
June 30, 2022 | -2.34% |
March 31, 2022 | 35.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-83.78%
Minimum
Mar 2023
98.00%
Maximum
Sep 2022
36.53%
Average
35.50%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 63.59% |
NovaBay Pharmaceuticals Inc | 68.19% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -219.6% |
Return on Assets | -107.4% |
Return on Invested Capital | -129.4% |
Profit Margin (Quarterly) | -531.4% |
Operating Margin (Quarterly) | -486.1% |
Return on Net Operating Assets | -933.1% |